Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Proceedings of the Western Pharmacology Society|January 7, 2005
An overview of some pharmacological methods used in safety pharmacology studiesMichael K PugsleyProceedings of the Western Pharmacology Society|January 19, 2006
The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetesMichael K PugsleyPharmacology & Therapeutics|March 28, 2002
The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular systemMichael K PugsleyCurrent Pharmaceutical Design|August 24, 2004
The opioid receptor independent actions of kappa receptor agonists in the cardiovascular systemMichael K PugsleyJournal of Pharmacological and Toxicological Methods|June 29, 2005
Methodology used in safety pharmacology: appraisal of the state-of-the-art, the regulatory issues and new directionsMichael K PugsleyJournal of Pharmacological and Toxicological Methods|October 24, 2025
Non-clinical cardiovascular safety testing: Current status, gaps and emerging trendsPeter Hoffmann, Michael K PugsleyProceedings of the Western Pharmacology Society|March 20, 2012
An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cellsElisa Vega-Avila, Michael K PugsleyJournal of Pharmacological and Toxicological Methods|June 30, 2006
Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance documentMichael K Pugsley, Michael J CurtisLife Sciences|November 13, 2002
Protamine is a low molecular weight polycationic amine that produces actions on cardiac muscleMichael K Pugsley, Vikram Kalra, Sarah Froebel-WilsonPharmacological Research|September 15, 2015
Charge is an important determinant of hemodynamic and adverse cardiovascular effects of cationic drugsMichael K Pugsley, Simon Authier, Michael J CurtisPageof 9